Ullrich disease: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Ullrich disease | |||
| synonyms = Ullrich congenital muscular dystrophy | |||
| field = [[Neurology]], [[Genetics]] | |||
| symptoms = [[Muscle weakness]], [[joint hypermobility]], [[contractures]], [[scoliosis]] | |||
| onset = [[Congenital]] | |||
| duration = [[Chronic]] | |||
| causes = Mutations in [[COL6A1]], [[COL6A2]], or [[COL6A3]] genes | |||
| risks = [[Genetic inheritance]] | |||
| diagnosis = [[Genetic testing]], [[muscle biopsy]], [[clinical evaluation]] | |||
| differential = [[Bethlem myopathy]], [[Merosin-deficient congenital muscular dystrophy]] | |||
| treatment = [[Physical therapy]], [[orthopedic interventions]], [[respiratory support]] | |||
| prognosis = Variable, depends on severity | |||
| frequency = Rare | |||
}} | |||
Ullrich Disease | Ullrich Disease | ||
Ullrich disease, also known as Ullrich congenital muscular dystrophy, is a rare genetic disorder characterized by muscle weakness and joint abnormalities. It is part of a group of conditions known as congenital muscular dystrophies. | Ullrich disease, also known as Ullrich congenital muscular dystrophy, is a rare genetic disorder characterized by muscle weakness and joint abnormalities. It is part of a group of conditions known as congenital muscular dystrophies. | ||
| Line 35: | Line 51: | ||
[[Category:Genetic Disorders]] | [[Category:Genetic Disorders]] | ||
[[Category:Muscular Dystrophies]] | [[Category:Muscular Dystrophies]] | ||
{{No image}} | {{No image}} | ||
Latest revision as of 05:16, 4 April 2025
| Ullrich disease | |
|---|---|
| Synonyms | Ullrich congenital muscular dystrophy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, joint hypermobility, contractures, scoliosis |
| Complications | N/A |
| Onset | Congenital |
| Duration | Chronic |
| Types | N/A |
| Causes | Mutations in COL6A1, COL6A2, or COL6A3 genes |
| Risks | Genetic inheritance |
| Diagnosis | Genetic testing, muscle biopsy, clinical evaluation |
| Differential diagnosis | Bethlem myopathy, Merosin-deficient congenital muscular dystrophy |
| Prevention | N/A |
| Treatment | Physical therapy, orthopedic interventions, respiratory support |
| Medication | N/A |
| Prognosis | Variable, depends on severity |
| Frequency | Rare |
| Deaths | N/A |
Ullrich Disease
Ullrich disease, also known as Ullrich congenital muscular dystrophy, is a rare genetic disorder characterized by muscle weakness and joint abnormalities. It is part of a group of conditions known as congenital muscular dystrophies.
Ullrich disease - overview[edit]
Ullrich disease is caused by mutations in the genes responsible for producing collagen VI, a protein crucial for the structural integrity of muscle tissue. The condition is named after Otto Ullrich, a German neurologist who first described it in the 1930s.
Symptoms[edit]
The symptoms of Ullrich disease can vary in severity but typically include:
- Muscle Weakness: Generalized muscle weakness is present from birth or early infancy.
- Joint Laxity: Hyperlaxity of distal joints, such as fingers and wrists, is common.
- Contractures: Tightness and contractures of proximal joints, such as elbows and knees, develop over time.
- Respiratory Issues: Some individuals may experience respiratory difficulties due to muscle weakness.
- Scoliosis: Curvature of the spine may occur in some patients.
Genetics[edit]
Ullrich disease is primarily caused by mutations in the COL6A1, COL6A2, or COL6A3 genes. These genes encode the alpha chains of collagen VI, a protein that forms a network around muscle fibers.
- Inheritance Pattern
The disease can be inherited in an autosomal dominant or autosomal recessive manner, depending on the specific genetic mutation involved.
Diagnosis[edit]
Diagnosis of Ullrich disease involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can confirm mutations in the collagen VI genes.
Treatment[edit]
There is currently no cure for Ullrich disease, but treatment focuses on managing symptoms and improving quality of life. This may include:
- Physical Therapy: To maintain muscle strength and flexibility.
- Orthopedic Interventions: Such as braces or surgery to manage joint contractures and scoliosis.
- Respiratory Support: In cases of respiratory muscle weakness.
Prognosis[edit]
The prognosis for individuals with Ullrich disease varies. Some may experience a stable course with mild symptoms, while others may have more severe progression leading to significant disability.
Research[edit]
Ongoing research is focused on understanding the molecular mechanisms of Ullrich disease and developing potential therapies, including gene therapy and protein replacement strategies.
See Also[edit]
References[edit]
- Ullrich, O. (1930). "On a congenital, atonic-sclerotic muscular dystrophy." *Journal of Neurology*. - Lampe, A. K., & Bushby, K. M. (2005). "Collagen VI related muscle disorders." *Journal of Medical Genetics*.
NIH genetic and rare disease info[edit]
Ullrich disease is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Ullrich disease
|